What is the expected growth forecast for the Therapeutic Radiopharmaceuticals market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Therapeutic Radiopharmaceuticals market?

Increasing cancer incidence and technological advancements drive the market.

What are the major challenges faced by the Therapeutic Radiopharmaceuticals market?

High development costs and regulatory hurdles are significant challenges.

Which regions are the leaders in the Therapeutic Radiopharmaceuticals market?

North America and Europe are the leading regions due to strong healthcare infrastructure.

Who are the top companies in the Therapeutic Radiopharmaceuticals market?

Companies like Bayer and Novartis are major players in the market.

What are the future opportunities in the Therapeutic Radiopharmaceuticals market?

Emerging markets and new indications offer future growth opportunities.

How does technology impact the Therapeutic Radiopharmaceuticals market?

Advances in technology improve treatment outcomes and patient safety.

What is the current regulatory landscape for Therapeutic Radiopharmaceuticals?

Stringent regulations and safety standards govern the market.

What is the future outlook for the Therapeutic Radiopharmaceuticals market size?

The market is expected to reach USD 2.5 billion by 2033, driven by increasing demand.

Therapeutic Radiopharmaceuticals Value Chain Analysis & Forecast Outlook 2033

Therapeutic Radiopharmaceuticals by Application (Thyroid, Bone Metastasis, Lymphoma, Other), by Types (Radium-223, Lutetium-177, Iodine-131, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Therapeutic Radiopharmaceuticals Market Size | CAGR 12.8 Forecast 2033

Therapeutic Radiopharmaceuticals Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Therapeutic Radiopharmaceuticals Market Overview

The Therapeutic Radiopharmaceuticals market refers to the industry that develops and manufactures radioactive drugs used to diagnose and treat various diseases, including cancer. As the global population ages and cancer incidence rates rise, the Therapeutic Radiopharmaceuticals market size is expected to witness significant growth, with a growth outlook that is driven by increasing demand for targeted and personalized therapies. The market forecast suggests that the industry will expand rapidly, driven by advancements in technology, rising healthcare expenditure, and growing awareness about the benefits of radiopharmaceuticals. The current Therapeutic Radiopharmaceuticals market size is approximately $4.8 billion, and it is expected to reach $14.3 billion by 2026, growing at a CAGR of 12.3% during the forecast period from 2026 to 2033.

Loading chart…

The Therapeutic Radiopharmaceuticals market is driven by several key forces, including technology shifts, such as the development of new radiopharmaceuticals and advancements in imaging technologies, regulations, such as the increasing use of radiopharmaceuticals in clinical trials, consumer behavior, such as the growing demand for targeted therapies, and competitive intensity, with several major players competing for market share. The largest region for the Therapeutic Radiopharmaceuticals market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing healthcare expenditure and growing awareness about the benefits of radiopharmaceuticals. Overall, the industry expansion is expected to be driven by the growing demand for radiopharmaceuticals, advancements in technology, and increasing investment in research and development.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer; Novartis; China Isotope & Radiation; Dongcheng; Q BioMed; Curium Pharmaceuticals; Jubilant Radiopharma; Lantheus; Aurobindo Pharma; International Isotopes; Mundipharma; GE Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Therapeutic Radiopharmaceuticals market is experiencing significant transformations, driven by various factors that impact its growth forecast and Therapeutic Radiopharmaceuticals market size. Understanding these dynamics is crucial for stakeholders to navigate the market effectively.

Growth Drivers2 items

Advancements in radiopharmaceutical technology are leading to the development of more targeted and effective treatments, thereby driving demand and contributing to the overall Therapeutic Radiopharmaceuticals market size.

Increasing cancer incidence rates globally are pushing the need for innovative therapies, including Therapeutic Radiopharmaceuticals, which in turn fuels the market's growth forecast.

Restraints2 items

High development costs and the lengthy approval process for new Therapeutic Radiopharmaceuticals can hinder the entry of new players and limit the growth forecast of the market.

Regulatory challenges, including stringent safety and efficacy standards, can impede the commercialization of Therapeutic Radiopharmaceuticals, affecting the overall Therapeutic Radiopharmaceuticals market size.

Opportunities2 items

Emerging markets offer significant opportunities for the Therapeutic Radiopharmaceuticals market due to their large and growing patient populations and increasing healthcare expenditures, which can substantially impact the Therapeutic Radiopharmaceuticals market size.

Collaborations between pharmaceutical companies and research institutions can accelerate the development of new Therapeutic Radiopharmaceuticals, driving innovation and contributing to a positive growth forecast.

Challenges2 items

The complexity of Therapeutic Radiopharmaceuticals manufacturing and supply chain management poses significant challenges, including ensuring consistent quality and availability, which can affect the Therapeutic Radiopharmaceuticals market size.

Pricing pressures and reimbursement issues can impact the profitability of Therapeutic Radiopharmaceuticals, making it essential for companies to develop strategies that balance affordability with the need for a positive growth forecast.

Market Segmentation

Loading chart…

The Therapeutic Radiopharmaceuticals segmentation by Application is a crucial aspect of the market, as it defines the specific use cases of these products. This segment includes various applications such as cancer treatment, pain management, and inflammatory disorders. Each application contributes to the overall Therapeutic Radiopharmaceuticals market size, with cancer treatment being the largest contributor due to the high prevalence of cancer globally.

The Types segment of the Therapeutic Radiopharmaceuticals market is further divided into subtypes, including alpha emitters, beta emitters, and brachytherapy. These subtypes have distinct characteristics and are used to treat specific conditions. Understanding the market taxonomy of these subtypes is essential to determine the overall market size and growth prospects. The alpha emitters subtype is expected to grow significantly due to its increasing adoption in cancer treatment.

Therapeutic Radiopharmaceuticals Segmentation Breakdown10 items

Application

Thyroid

Bone Metastasis

Lymphoma

Other

Types

Radium-223

Lutetium-177

Iodine-131

Other

Regional Insights

Loading chart…

The Therapeutic Radiopharmaceuticals market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of radiopharmaceuticals, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and significant investments in research and development. In Europe, drivers include a well-established infrastructure, favorable policies, and a high level of adoption. Asia Pacific is driven by growing demographics, increasing adoption, and significant investments in healthcare. Latin America and Middle East & Africa are driven by growing demographics, increasing adoption, and improving infrastructure.

Regional Insights5 items

North America: mature ecosystem, high demographics awareness, significant investments

Europe: well-established infrastructure, favorable policies, high adoption

Asia Pacific: growing demographics, increasing adoption, significant investments

Latin America: growing demographics, increasing adoption, improving infrastructure

Middle East & Africa: growing demographics, increasing adoption, improving infrastructure

Competitive Landscape

The Therapeutic Radiopharmaceuticals market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The Therapeutic Radiopharmaceuticals competitive landscape is characterized by high competition, with companies focusing on differentiation through innovative products and services. Global players are expanding their presence through strategic partnerships and acquisitions, while local companies are emphasizing regional expertise and customized solutions.

Companies in the Therapeutic Radiopharmaceuticals market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must adapt to changing market dynamics and evolving customer needs.

Bayer: regional expansion

Novartis: innovation pipeline

China Isotope & Radiation: local manufacturing

Dongcheng: OEM tie-ups

Q BioMed: premium pricing

Curium Pharmaceuticals: vertical integration

Key Therapeutic Radiopharmaceuticals Companies12 items

Bayer

Novartis

China Isotope & Radiation

Dongcheng

Q BioMed

Curium Pharmaceuticals

Jubilant Radiopharma

Lantheus

Aurobindo Pharma

International Isotopes

Mundipharma

GE Healthcare

Market Ecosystem

The Therapeutic Radiopharmaceuticals ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers to downstream end users. Value is created and captured through the development, manufacturing, and distribution of radiopharmaceuticals, which are used to treat various diseases. The ecosystem can be broadly categorized into three segments: upstream, midstream, and downstream, with each segment playing a crucial role in the value chain analysis of Therapeutic Radiopharmaceuticals.

Raw material/component suppliers — providing radioactive isotopes

OEMs / manufacturers — producing radiopharmaceuticals

Technology providers — developing new radiopharmaceutical technologies

System integrators / EPCs — integrating radiopharmaceuticals into treatment protocols

Distributors / channel partners — distributing radiopharmaceuticals to healthcare providers

Regulators/standards bodies — establishing safety and efficacy standards

End users / buyers — healthcare providers administering radiopharmaceuticals

The flow of value in the Therapeutic Radiopharmaceuticals ecosystem is influenced by various control points, including regulatory approvals and reimbursement policies. Dependency risks, such as input constraints and standards, can also impact the ecosystem. Additionally, switching costs and partnerships between stakeholders can affect the adoption of new radiopharmaceuticals. The ecosystem may differ by region, with varying levels of access to radiopharmaceuticals and treatment protocols. Understanding these dynamics is essential for navigating the Therapeutic Radiopharmaceuticals ecosystem.

Recent Industry Insights

The Therapeutic Radiopharmaceuticals industry has witnessed significant developments over the last 12-18 months, shaping the future of Therapeutic Radiopharmaceuticals industry trends. Recent partnerships, such as collaborations between pharmaceutical companies and research institutions, have accelerated the development of new radiopharmaceuticals. Additionally, mergers and acquisitions have led to the expansion of product portfolios and geographical reach.

Furthermore, the launch of new products and technologies has improved treatment options for patients. Regulatory changes, such as the FDA's approval of new radiopharmaceuticals, have also contributed to the growth of the industry. A shift in consumer trends towards personalized medicine has driven the demand for targeted therapies, including radiopharmaceuticals. Funding rounds and expansions have enabled companies to invest in research and development, driving innovation in the Therapeutic Radiopharmaceuticals industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Therapeutic Radiopharmaceuticals market outlook. The market exhibits high attractiveness due to increasing demand for targeted therapies and a growing patient population. The competitive intensity is moderate, with key players investing in research and development to expand their product portfolios. The long-term outlook is positive, driven by advancements in technology and the potential for new indications. The innovation landscape is dynamic, with ongoing research in areas like cancer treatment. However, the demand–supply balance is challenging, with manufacturing complexities and regulatory hurdles affecting supply. Key risk factors include supply chain disruptions and regulatory changes. Overall, the Therapeutic Radiopharmaceuticals market outlook is promising, with opportunities for growth and innovation.

11 items

1. Executive Summary

2. Therapeutic Radiopharmaceuticals Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Therapeutic Radiopharmaceuticals Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Therapeutic Radiopharmaceuticals Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Thyroid

6.1.2. Bone Metastasis

6.1.3. Lymphoma

6.1.4. Other

6.2. Global Therapeutic Radiopharmaceuticals Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Radium-223

6.2.2. Lutetium-177

6.2.3. Iodine-131

6.2.4. Other

6.3. Global Therapeutic Radiopharmaceuticals Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Therapeutic Radiopharmaceuticals Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Therapeutic Radiopharmaceuticals Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Therapeutic Radiopharmaceuticals Market Competition by Key Manufacturers

8.1. Global Therapeutic Radiopharmaceuticals Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Therapeutic Radiopharmaceuticals: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Bayer

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Novartis

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. China Isotope & Radiation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Dongcheng

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Q BioMed

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Curium Pharmaceuticals

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Jubilant Radiopharma

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Lantheus

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Aurobindo Pharma

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. International Isotopes

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Mundipharma

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. GE Healthcare

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Therapeutic Radiopharmaceuticals Market

Figure 4: Global Therapeutic Radiopharmaceuticals Market: Drivers

Figure 5: Global Therapeutic Radiopharmaceuticals Market: Challenges

Figure 6: Global Therapeutic Radiopharmaceuticals Market: Trends

Figure 7: Global Therapeutic Radiopharmaceuticals Market: Opportunity

Figure 8: Global Therapeutic Radiopharmaceuticals Market: Restraint

Figure 9: Global Therapeutic Radiopharmaceuticals Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Therapeutic Radiopharmaceuticals Market Value (USD Million) By Region

Figure 15: Global Therapeutic Radiopharmaceuticals Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Therapeutic Radiopharmaceuticals Market Value (USD Million) By Region

Figure 23: Global Therapeutic Radiopharmaceuticals Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Therapeutic Radiopharmaceuticals Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Therapeutic Radiopharmaceuticals Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Therapeutic Radiopharmaceuticals Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Therapeutic Radiopharmaceuticals Market Value (USD Million) By Region

Table 10: Global Therapeutic Radiopharmaceuticals Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Therapeutic Radiopharmaceuticals Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Therapeutic Radiopharmaceuticals Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Therapeutic Radiopharmaceuticals Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Bayer Basic Information And Sales Area

Table 31: Bayer. Products Portfolio

Table 32: Novartis Basic Information And Sales Area

Table 33: Novartis. Products Portfolio

Table 34: China Isotope & Radiation Basic Information And Sales Area

Table 35: China Isotope & Radiation. Products Portfolio

Table 36: Dongcheng Basic Information And Sales Area

Table 37: Dongcheng. Products Portfolio

Table 38: Q BioMed Basic Information And Sales Area

Table 39: Q BioMed. Products Portfolio

Table 40: Curium Pharmaceuticals Basic Information And Sales Area

Table 41: Curium Pharmaceuticals. Products Portfolio

Table 42: Jubilant Radiopharma Basic Information And Sales Area

Table 43: Jubilant Radiopharma. Products Portfolio

Table 44: Lantheus Basic Information And Sales Area

Table 45: Lantheus. Products Portfolio

Table 46: Aurobindo Pharma Basic Information And Sales Area

Table 47: Aurobindo Pharma. Products Portfolio

Table 48: International Isotopes Basic Information And Sales Area

Table 49: International Isotopes. Products Portfolio

Table 50: Mundipharma Basic Information And Sales Area

Table 51: Mundipharma. Products Portfolio

Table 52: GE Healthcare Basic Information And Sales Area

Table 53: GE Healthcare. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Therapeutic Radiopharmaceuticals Market Value (USD Million) By Region

Table 59: Global Therapeutic Radiopharmaceuticals Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Therapeutic Radiopharmaceuticals Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.15 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bayer; Novartis; China Isotope & Radiation; Dongcheng; Q BioMed; Curium Pharmaceuticals; Jubilant Radiopharma; Lantheus; Aurobindo Pharma; International Isotopes; Mundipharma; GE Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options